Skip to main content

Day: June 18, 2025

Net asset value of the EfTEN United Property Fund as of 31.05.2025

EfTEN United Property Fund earned a net profit of 170 thousand euros in May and 1,32 million euros in the first five months of 2025 (compared to 357 thousand euros in the same time last year). In May, the fund made a cash distribution to investors in the amount of 1.47 million euros, or 57-euro cents per unit. As a result, the fund’s net asset value (NAV) decreased by 4,4% and was 11,02 euros per unit at the end of May. Without the distribution the NAV of EfTEN United Property Fund would have increased by 0,6% in May. The fund’s largest investment, the EfTEN Real Estate Fund 5, of which EfTEN United Property Fund owns 36.5%, earned a profit of 257 thousand euros in May. Performance of the EfTEN Real Estate Fund 5 was primarily supported by the investment in Kristiine shopping centre, completed in December last year. As of the...

Continue reading

Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system

Louvain-la-Neuve, Belgium, June 18, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide X-ray Solution. IBA’s solution will be installed at Steri-Tek’s service center near Dallas-Fort Worth Metro Area, Texas, which was opened in 2023. This strategically located facility is positioned to serve a growing customer base, as well as creating logistical efficiencies. The addition of the Be Wide solution to their existing X-ray sterilization offering will increase Steri-Tek’s processing capacity fivefold, by enabling the sterilization of full pallets with a wider range of product densities,...

Continue reading

GAM Holding AG appoints Albert Saporta as Group Chief Executive Officer and Tim Rainsford as Group Chief Distribution Officer

Tim Rainsford_GAMTim Rainsford – Incoming Chief Distribution Officer, GAMAlbert Saporta_GAMAlbert Saporta – New Group CEO, GAMZurich: 18 June 2025 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM Holding AG appoints Albert Saporta as Group Chief Executive Officer and Tim Rainsford as Group Chief Distribution Officer GAM Holding AG (SWX: GAM) today announces senior leadership changes as the Group moves into the next phase of sustainable growth. Albert Saporta has been appointed Group Chief Executive Officer (Group CEO) effective from 1 July 2025, succeeding Elmar Zumbuehl who will remain with GAM until 31 December 2025 to support the transition. Additionally, Tim Rainsford will return to GAM to lead its distribution efforts as Group Chief Distribution Officer on 1 October 2025. These...

Continue reading

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Geneva, Switzerland, June 18, 2025 – Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will issue its Q1 2025 Financial Results on June 19, 2025. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) the same day. Title:   Addex Therapeutics Q1 2025 financial results and corporate update Date: June 19, 2025Time: 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) Joining the Conference Call:Participants are required to register in advance of the conference using the link...

Continue reading

SIKA STRENGTHENS GLOBAL PRESENCE WITH STRATEGIC INVESTMENTS ACROSS ALL REGIONS

SIKA STRENGTHENS GLOBAL PRESENCE WITH STRATEGIC INVESTMENTS ACROSS ALL REGIONS Sika continues to deliver on its Local-for-Local strategy with the launch of three new manufacturing investments in China, Brazil, and Morocco—reinforcing its commitment to serving customers with local production, global expertise, and sustainable innovation. By expanding its footprint in these markets, Sika is actively executing its growth strategy—strengthening its global presence and laying the groundwork for future expansion. These site developments are part of a broader effort to increase market penetration, and ensure that production capabilities are aligned with customer needs at a regional level. In the fast-growing metropolitan hub of Suzhou, Sika has extended its existing site to support China’s urban development. Serving a region of more than 12...

Continue reading

Biomea Fusion Announces Pricing of Public Offering of Securities

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced the pricing of its previously announced underwritten public offering consisting of (i) 19,450,000 shares of its common stock and accompanying warrants to purchase an aggregate of 19,450,000 shares of common stock (or pre-funded warrants in lieu thereof) and (ii) in lieu of common stock, to certain investors, pre-funded warrants to purchase an aggregate of up to 550,000 shares of its common stock and accompanying warrants to purchase an aggregate of 550,000 shares of common stock (or pre-funded warrants in lieu thereof), at an exercise price of $0.0001 per pre-funded warrant. In addition, Biomea has granted the underwriters a 30-day option to purchase up to an additional...

Continue reading

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

~Record Participation for SBC Medical. 22 doctors Present Insights in Their Respective Fields~ IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”) today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty Clinic, a clinic operated under the management support of SBC Medical Group, a consolidated subsidiary, presented their research findings at “The 113th Congress of Japan Society of Aesthetic Surgery.” Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings Incorporated The Japan Society of Aesthetic Surgery (JSAS), one of Japan’s leading professional societies in the field of aesthetic medicine, brings together doctors dedicated to shaping the future of the industry. “The 113th Congress of Japan...

Continue reading

High Arctic Overseas Announces Normal Course Issuer Bid

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 17, 2025 (GLOBE NEWSWIRE) — High Arctic Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by the Corporation of its intention to make a Normal Course Issuer Bid (the “Bid”) to be transacted through the facilities of the Exchange. The notice provides that the Corporation may, during the 12-month period commencing June 20, 2025 and ending June 19, 2026 purchase up to 622,408 Common Shares (“Shares”) in total, being approximately 5% of the total number...

Continue reading

EHang and Gotion High-Tech Join Forces to Power the Future of Low-Altitude Economy

GUANGZHOU, China, June 18, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading Urban Air Mobility (“UAM”) technology platform company, today announced the expansion of its strategic partnership with Gotion High-Tech Co., Ltd. (“Gotion”), a leading innovator in power battery solutions. Building on a power system framework agreement signed in December 2023, this enhanced collaboration marks a significant step forward in powering the electric vertical take-off and landing (“eVTOL”) aircraft. Under the upgraded partnership, the two companies will jointly advance the development of power systems for EHang’s flagship EH216 series of pilotless eVTOL aircraft, with plans to extend their collaboration to future aircraft models. By leveraging cutting-edge battery technologies, the partnership...

Continue reading

Pioneer Acquisition I Corp Announces Pricing of $220,000,000 Initial Public Offering

BROOKLYN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — Pioneer Acquisition I Corp (Nasdaq: PACHU) (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “PACHU” beginning June 18, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PACH” and “PACHW”, respectively. The underwriter has been granted a 45-day option to purchase up to an additional 3,300,000 units offered by the Company to cover over-allotments, if any. The offering is expected to close on June 20, 2025, subject...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.